Company intelligence / Profile preview

Davids

Regensburg, Bavaria, Germany

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Davids Biotechnologie is a German life sciences company specializing in custom antibody production and related immunological services. Founded in 1996, the company provides a comprehensive suite of services including the development of polyclonal antibodies in various species and the generation of monoclonal antibodies using hybridoma technology. In addition to antibody production, Davids offers protein expression in pro- and eukaryotic systems, protein purification, and the development of diagnostic assays such as ELISA. The company serves academic research institutions, diagnostic companies, and the pharmaceutical industry globally, operating out of its facility in Regensburg.

Modalities: AntibodyMonoclonal antibodyPolyclonal antibodyRecombinant protein
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Davids.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Davids.

Explore the full profile